Amneal Pharmaceuticals
AMRX
AMRX
153 hedge funds and large institutions have $666M invested in Amneal Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
+9
Holders Change %
+6.25%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
34
Increased
52
Reduced
44
Closed
25
Calls
$3.58M
Puts
$92K
Net Calls
+$3.49M
Net Calls Change
+$2.83M
Top Buyers
| 1 |
RCMNY
1
Rubric Capital Management (New York)
New York
|
$48.6M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$39.4M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$8.92M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$17.1M |
| 5 |
5
BlackRock
New York
|
$53.7M |
Top Sellers
| 1 |
EP
1
Eversept Partners
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$2.05M |
| 3 |
3
Arrowstreet Capital
Boston,
Massachusetts
|
$1.29M |
| 4 |
4
Millennium Management
New York
|
$0 |
| 5 |
5
JPMorgan Chase & Co
New York
|
$1.13M |
